Literature DB >> 33874962

Inhibiting BDNF/TrkB.T1 receptor improves resiniferatoxin-induced postherpetic neuralgia through decreasing ASIC3 signaling in dorsal root ganglia.

Xiang Wei1, Lina Wang1, Jie Hua1, Xiao-Hong Jin1, Fuhai Ji1, Ke Peng1, Bin Zhou2,3, Jianping Yang4, Xiao-Wen Meng5.   

Abstract

BACKGROUND: Postherpetic neuralgia (PHN) is a devastating complication after varicella-zoster virus infection. Brain-derived neurotrophic factor (BDNF) has been shown to participate in the pathogenesis of PHN. A truncated isoform of the tropomyosin receptor kinase B (TrkB) receptor TrkB.T1, as a high-affinity receptor of BDNF, is upregulated in multiple nervous system injuries, and such upregulation is associated with pain. Acid-sensitive ion channel 3 (ASIC3) is involved in chronic neuropathic pain, but its relation with BDNF/TrkB.T1 in the peripheral nervous system (PNS) during PHN is unclear. This study aimed to investigate whether BDNF/TrkB.T1 contributes to PHN through regulating ASIC3 signaling in dorsal root ganglia (DRGs).
METHODS: Resiniferatoxin (RTX) was used to induce rat PHN models. Mechanical allodynia was assessed by measuring the paw withdrawal thresholds (PWTs). Thermal hyperalgesia was determined by detecting the paw withdrawal latencies (PWLs). We evaluated the effects of TrkB.T1-ASIC3 signaling inhibition on the behavior, neuronal excitability, and inflammatory response during RTX-induced PHN. ASIC3 short hairpin RNA (shRNA) transfection was used to investigate the effect of exogenous BDNF on inflammatory response in cultured PC-12 cells.
RESULTS: RTX injection induced mechanical allodynia and upregulated the protein expression of BDNF, TrkB.T1, ASIC3, TRAF6, nNOS, and c-Fos, as well as increased neuronal excitability in DRGs. Inhibition of ASIC3 reversed the abovementioned effects of RTX, except for BDNF and TrkB.T1 protein expression. In addition, inhibition of TrkB.T1 blocked RTX-induced mechanical allodynia, activation of ASIC3 signaling, and hyperexcitability of neurons. RTX-induced BDNF upregulation was found in both neurons and satellite glia cells in DRGs. Furthermore, exogenous BDNF activated ASIC3 signaling, increased NO level, and enhanced IL-6, IL-1β, and TNF-α levels in PC-12 cells, which was blocked by shRNA-ASIC3 transfection.
CONCLUSION: These findings demonstrate that inhibiting BDNF/TrkB.T1 reduced inflammation, decreased neuronal hyperexcitability, and improved mechanical allodynia through regulating the ASIC3 signaling pathway in DRGs, which may provide a novel therapeutic target for patients with PHN.

Entities:  

Keywords:  Acid-sensitive ion channel 3; Brain-derived neurotrophic factor; Neuronal excitability; Postherpetic neuralgia; Resiniferatoxin; Truncated tropomyosin receptor kinase B receptor

Year:  2021        PMID: 33874962     DOI: 10.1186/s12974-021-02148-5

Source DB:  PubMed          Journal:  J Neuroinflammation        ISSN: 1742-2094            Impact factor:   8.322


  46 in total

1.  Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine.

Authors:  Hung Fu Tseng; Bruno Lewin; Craig M Hales; Lina S Sy; Rafael Harpaz; Stephanie Bialek; Yi Luo; Steven J Jacobsen; Kavya Reddy; Po-Yin Huang; Jeff Zhang; Sean Anand; Erin Mary Bauer; Jennifer Chang; Sara Y Tartof
Journal:  J Infect Dis       Date:  2015-06-01       Impact factor: 5.226

Review 2.  The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy.

Authors:  M Notaras; R Hill; M van den Buuse
Journal:  Mol Psychiatry       Date:  2015-03-31       Impact factor: 15.992

Review 3.  Pharmacotherapy of neuropathic pain: which drugs, which treatment algorithms?

Authors:  Nadine Attal; Didier Bouhassira
Journal:  Pain       Date:  2015-04       Impact factor: 6.961

Review 4.  Neurological complications of varicella zoster virus reactivation.

Authors:  Maria A Nagel; Don Gilden
Journal:  Curr Opin Neurol       Date:  2014-06       Impact factor: 5.710

Review 5.  Brain-derived neurotrophic factor as a driving force behind neuroplasticity in neuropathic and central sensitization pain: a new therapeutic target?

Authors:  Jo Nijs; Mira Meeus; Jan Versijpt; Maarten Moens; Inge Bos; Kristel Knaepen; Romain Meeusen
Journal:  Expert Opin Ther Targets       Date:  2014-12-18       Impact factor: 6.902

6.  Brain-Derived Neurotrophic Factor (BDNF): Novel Insights into Regulation and Genetic Variation.

Authors:  Michael Notaras; Maarten van den Buuse
Journal:  Neuroscientist       Date:  2018-11-02       Impact factor: 7.519

Review 7.  Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation.

Authors:  Bruno Lima Giacobbo; Janine Doorduin; Hans C Klein; Rudi A J O Dierckx; Elke Bromberg; Erik F J de Vries
Journal:  Mol Neurobiol       Date:  2018-08-17       Impact factor: 5.590

Review 8.  Neurobiology of BDNF in fear memory, sensitivity to stress, and stress-related disorders.

Authors:  Michael Notaras; Maarten van den Buuse
Journal:  Mol Psychiatry       Date:  2020-01-03       Impact factor: 15.992

9.  Brain-derived neurotrophic factor derived from sensory neurons plays a critical role in chronic pain.

Authors:  Shafaq Sikandar; Michael S Minett; Queensta Millet; Sonia Santana-Varela; Joanne Lau; John N Wood; Jing Zhao
Journal:  Brain       Date:  2018-04-01       Impact factor: 13.501

Review 10.  Postherpetic Neuralgia: Current Evidence on the Topical Film-Forming Spray with Bupivacaine Hydrochloride and a Review of Available Treatment Strategies.

Authors:  Anh L Ngo; Ivan Urits; Melis Yilmaz; Luc Fortier; Anthony Anya; Jae Hak Oh; Amnon A Berger; Hisham Kassem; Manuel G Sanchez; Alan D Kaye; Richard D Urman; Edwin W Herron; Elyse M Cornett; Omar Viswanath
Journal:  Adv Ther       Date:  2020-04-15       Impact factor: 3.845

View more
  1 in total

1.  Resting-State Functional Connectivity Analyses: Brain Functional Reorganization in a Rat Model of Postherpetic Neuralgia.

Authors:  Shuting Han; Guanzuan Wu; Xiang Wei; Xiaowen Meng; Fengchao Zang; Lan Shen; Hui Dai; Lina Wang; Yonggang Li
Journal:  Brain Sci       Date:  2022-08-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.